Evidence evaluation in rare disease guidelines: a methodological perspective
Monoclonal gammopathies and their management in Gaucher disease type 1
Neurofibromatosis type 2-related schwannomatosis: an update
Management strategies for systemic lupus erythematosus using kinase inhibitors
Emerging treatments for systemic lupus erythematosus
All published articles are preserved here permanently: